CClinicalTrials.gg
Active, not recruitingNCT07625046FGUpdated Aug 31, 2026

How Fig Polyphenols Affect Blood Sugar and Insulin Levels After Eating in Adults at Risk for Diabetes

An interventional study of Fig and Control in Pre Diabetic, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology. Active, not recruiting at 1 site in United States. Open to female participants aged 30 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-31.

Sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Randomized
Ages
30 Years to 50 Years
Sex
Female
01

Study summary

The study purpose is to understand how the body absorbs and metabolizes nutrient-like components in dried figs called polyphenols over 24 hours. The study is also done to know if polyphenols will help a hormone called insulin work better in the body, so to look further into the possibility of figs being a functional food for the pre-diabetic population.

Read the detailed description

Recruited subjects must meet all eligibility criteria, sign and date a written Institutional Review Board (IRB)-approved Informed Consent Form.

The trial will test 2 dietary conditions which will be either the equivalent of one serving of dried California Mission Figs (40 g, \~120 kcal) or a calorie-matched control meal.

Pre-Screening: To learn more about the study and to pre-qualify, potential subjects can call the CNRC or visit the website posted on recruitment flyers or from other recruitment materials. If they call the CNRC, a staff member will provide a brief background on the study and ask a series of questions from a pre-screening questionnaire to see if they may be eligible to participate. The same questionnaire is available on the website and can be filled out by potential subjects online. The pre-screening questionnaire includes self-reported information about health status and lifestyle factors that can be used to determine if someone is not eligible for the study.

Information Session and Screening Session: Information Session and Screening Visit may occur simultaneously, or Information Session may occur prior to Screening Visit. Prior to the Screening Visit, potential subjects will be asked to arrive at the CNRC after an overnight-fast (stop eating after 10 pm) and be well-hydrated. Subjects should aim for drinking at least 8-10 cups of water the 24 h prior to the Screening Visit.

Information Session: At the CNRC, pre-screened subjects will participate in an Information Session where they will be informed of all study procedures and study schedules. If willing to adhere to all study procedures and schedules, they will be asked to read, ask questions, sign and date the Institutional Review Board (IRB) approved Informed Consent Form (ICF) before any laboratory or study screening procedures begin.

Screening Visit: After meeting eligibility criteria for blood glucose (BG) and blood pressure (BP) measures, subjects will advance to further screening procedures which will include anthropometric measurements (height, weight, waist circumference, body composition), BMI (calculated from height and weight), medical history, prior and concomitant medication, and dietary supplements use, and completion of a series of questionnaires relating to their general health and lifestyle. Woman under the age of 60 year, will be required to take a pregnancy test.

Pre-Study Visit: If the subject is qualified based on the screening results, the Pre-Study visit will take place immediately after the screening or on a later date. This visit lasts approximately 30-45 minutes, during which the subject will meet with one of the investigators who will provide detailed instructions on the study procedures and how to prepare for each study day. They will also receive training on study procedures, including dietary restrictions, medications and supplements to avoid, food recording, and overnight fasting requirements. The study dates will be scheduled, and they will receive a study booklet containing the study calendar and all the instructions covered during the Pre-Study visit.

Test Day Visits: The study is of two weeks with each visit having a follow up visit for a 24 hr blood draw. We will collect the three-day food record and verify that the subjects have fasted overnight, consumed a standardized dinner meal, avoided the specified food items, had sufficient sleep, and maintained dietary and exercise patterns consistent with the study procedures. Once everything is confirmed, we will measure their weight, body composition, vital signs (blood pressure, heart rate, and forehead temperature), and check their fasting blood glucose with a finger prick test. The visits include blood collection, urine collection, filling of the Online Dietary Questionnaire (ASA24) and GI tract diary. During each of the two study visits, blood will be collected eight times per visit, with a total of 120 mL of blood collected and four urine collection throughout the study across all visits.

02

Conditions studied

  • Pre Diabetic

Browse trials for

Keywords

  • dried figs
  • pre-diabetic
  • Pharmacokinetics
03

Who can participate

Ages eligible
30 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Be between 30-50 years old.
  • Have a BMI of 25-35 kg/m².
  • Have fasting blood glucose between 100-125 mg/dL or Glycated hemoglobin (HbA1c) between 5.7-6.4%.
  • Be non-smokers for at least 12 months.
  • Be generally healthy, with no major organ-related diseases.
  • Not take medications or supplements that could interfere with the study.
  • Be able to follow study procedures, including dietary restrictions and scheduled visits

Exclusion criteria

Exclusion Criteria:

  • Smoker
  • Vegetarian
  • Taking over the counter supplements (e.g. fiber supplements, probiotics and/or prebiotics, antioxidants, anti-inflammation) and/or taking prescription medications that may interfere with study procedures or endpoints (e.g. Gastrointestinal medications, antibiotics) within the last 30 days
  • Have cancer other than non-melanoma skin cancer in previous 5 years
  • Taking unstable dose of hormonal contraceptive and/or stable dose less than 6 months
  • Planning to become pregnant
  • Pregnant and/or breast-feeding
  • Excessive exercisers or trained athletes
  • Excessive coffee/tea drinker
  • Donated blood within last 3 months
  • Have allergies/intolerances to foods consumed in the study
  • Regular consumption of dried fruits exceeds > 2 servings per day
  • Actively losing weight/ trying to lose weight (unstable body weight fluctuations of > 5 lbs in 3 months)
  • Addicted to drugs or alcohol or have significant psychiatric or neurological disturbances
  • Past smokers may be allowed in the study if stopped >2 years
04

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
5 participants (estimated)

Study arms

  • Experimental
    Fig Breakfast

    Standardized breakfast with 40g of figs

    Other: Fig

  • Placebo comparator
    Control breakfast

    Standardized breakfast with calorie matched control ingredients

    Other: Control

Interventions

  • OtherFig

    40g of fig

  • OtherControl

    Calorie matched control breakfast

05

What researchers measure

Primary outcomes

  1. Blood glucose levels

    Blood glucose levels with and without dried figs.

    Time frame: From enrollment to the end of treatment at 2 weeks

  2. Blood Insulin levels

    Blood insulin levels with and without dried figs.

    Time frame: From enrollment to the end of treatment at 2 weeks

Secondary outcomes

  1. Polyphenols

    Concentrations of fig polyphenol metabolites in the blood and urine over time

    Time frame: From enrollment to the end of treatment at 2 weeks

06

Study locations

1 site
  • Illinois Tech
    Chicago, Illinois 60616, United States
07

References and documents

Individual participant data

Plan to share: No — Pilot study

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07625046
Lead sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology
Responsible party
Sponsor
First posted
Jun 4, 2026
Start date
Mar 12, 2026
Primary completion
May 22, 2026
Completion
May 15, 2027 (estimated)
Last update
Aug 31, 2026

Study contacts

Amandeep Sandhu, PHD
principal investigator · Food Sci and Nut Programs

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion